Management of Anaphylaxis

Agustinus Evrianto Irawan

doi:10.37287/jppp.v2i4.180

Agustinus Evrianto Irawan Universitas Lampung

DOI: https://doi.org/10.37287/jppp.v2i4.180

Keywords: anaphylaxis, shock anaphylactic, therapy

Abstract

Anaphylaxis is a type-I hypersensitivity reaction which involves various organ system with rapid onset and life-threatening. This reaction present as abnormality on airway, circulation, digestion, and changes of skin and mucose. The aim of this literature review is to explain correct treatment for anaphylaxis. This literature review uses 23 article which were fetched from NCBI and 1 book which are all published in range of year 2000-2020. Keywords used in this literature searching are shock anaphylactic, anaphylaxis, and therapy and publication range filter from 2010-2020 was used. The liiterature searching yielded 4666 articles which were then 23 of them were chosen according to needed information. References were picked and further analyzed with systematic literature review method which consists of collecting, evaluating, and developing the research with certain topics. The result of this review shosws that the administration of epinephrine is key in treating anaphylaxis. Decontamination, evaluation of vital signs, positioning, oxygen therapy, and fluid rescucitation are also vital. Adjuvant therapy with anti-allergy medications should be considered to relieve patient's symptoms

References

Alvarez-Perea, A., Tanno, L., & Baeza, M. (2017). How to Manage Anaphylaxis in Primary Care. Clin Transl Allergy, 7, 45. https://doi.org/10.1186/s13601-017-0182-7

Irani, A., & Akl, E. (2015). Management and Prevention of Anaphylaxis. F1000Research, 4(F1000 Faculty Rev), 1492. https://doi.org/10.12688/f1000research.7181.1

Kounis, N., Soufras, G., & Hahalis, G. (2013). Anaphylactic Shock : Kounis Hypersensitivity - Associated Syndrome Seems to be the Primary Cause. N Am J Med Sci, 5(11), 631–636. https://doi.org/10.4103/1947-2714.122304

Lee, A., Thalayasingam, M., & Lee, B. (2013). Food Allergy in Asia : How Does it Compare? Asia Pacific Allergy, 3(1), 3–14. https://doi.org/10.5415/apallergy.2013.3.1.3

Lertnawapan, R., & Maek-a-nantawat, W. (2011). Anaphylaxis and Biphasic Phase in Thailand : 4-Year Observation. Allergol Int, 60(3), 283–289. https://doi.org/10.2332/allergolint.10-OA-0256

Lieberman, P. (2012). The Risk and Management of Anaphylaxis in the Setting of Immunotherapy. American Journal of Rhinology and Allergy, 26(6), 469–474. https://doi.org/10.2500/ajra.2012.26.3811

Liew, W., Williamson, E., & Tang, M. (2009). Anaphylaxis Fatalities and Adminissions in Australia. J Allergy Clin Immunol, 123(2), 434–442. https://doi.org/10.1016/j.jaci.2008.10.049

Mangold, M., & Qureshi, M. Neurologic Manifestations in Anaphylaxis due to Subcutaneous Allergy Immunotherapy : A Case Report. , (2018).

McLendon, K., & Sternard, B. (2020). Anaphylaxis. Finlandia: StatPearls Publishing.

Mullins, R. (2003). Anaphylaxis : Risk Factors for Recurrence. Clin Exp Allergy, 33(8), 1033–1040. https://doi.org/10.1046/j.1365-2222.2003.01671.x

Muraro, A., Roberts, G., Worm, M., Bilo, M., & Brockow, K. (2014). Anaphylaxis : Guidelines from the European Academy of Allergy and Clinical Immunology. Allergy, 69(8), 1026–1045. https://doi.org/10.1111/all.12437

Muraro, A., Werfel, T., Hoffmann-Sommergruber, K., & Roberts, G. (2014). EAACI Food Allergy and Anaphylaxis Guidelines : Diagnosis and Management of Food ALlergy. Allergy, 69, 1008–1025. https://doi.org/10.1111/all.12429

Nguyen, K., & Kohli, A. (2020). Latex Allergy. Finlandia: StatPearls Publishing.

Patel, D., Holdford, D., Edwards, E., & Caroll, N. (2011). Estimating the Economic Burden of Food-induced Allergy Reactions and Anaphylaxis in the United States. J Allergy Clin Immunol, 128(1), 110–115. https://doi.org/10.1016/j.jaci.2011.03.013

Pumphrey, R. (2000). Lessons for Management of Anaphylaxis from A Study of Fatal Reactions. Clin Experim Allergy, 30, 1144–1150. https://doi.org/10.1046/j.1365-2222.2000.00864.x

Pumphrey, R. (2003). Fatal Posture in Anaphylactic Shock. Allergy Clin Immunol, 112(2), 451–452. https://doi.org/10.1067/mai.2003.1614

Reber, L., & Hernandez, J. (2017). The Pathophysiology of Anaphylaxis. The Journal of Allergy and Clinical Immunology, 140(2), 335–348. https://doi.org/10.1016/j.jaci.2017.06.003

Reed, J., Yedulapuram, M., Lieberman, P., & Fitzpatrick, E. (2006). Differences in Cytokine Production Between Idiopathic Anaphylaxis (IA) Subjects and Controls. J Allergy Clin Immunol, 117(Suppl), 305.

Ring, J., Beyer, K., Biedermann, T., & Bircher, A. (2014). Guideline for Acute Therapy and Management of Anaphylaxis. Allegro J Int, 23(3), 96–112. https://doi.org/10.1007/s40629-014-0009-1

Sreevastava, D., & Tarneja, V. (2003). Anaphylactic Reaction : An Overview. Medical Journal, Armed Forces India, 59(1), 53–56. https://doi.org/10.1016/S0377-1237(03)80109-0

Thong, B., Cheng, Y., Leong, K., Tang, C., & Chng, H. (2007). Immediate Food Hypersensitivity Among Adults Attending A Clinical Immunology / Allergy Centre in Singapore. Singapore Med J, 48(3), 236–240.

Tupper, J., & Visser, S. (2010). Anaphylaxis : A Review and Update. Can Fam Physician, 56(10), 1009–1011.

Turner, P., Jerschow, E., Umasunthar, T., Lin, R., Campbell, D., & Boyle, R. (2017). Fatal Anaphylaxis : Mortality Rate and Risk Factors. The Journal of Allergy and Clinical Immunology, 5(5), 1169–1178. https://doi.org/10.1016/j.jaip.2017.06.031

Wood, R., Camargo, C. J., & Lieberman, P. (2014). Anaphylaxis in America : The Prevalence and Characteristics of Anaphylaxis in the United States. J Allergy Clin Immunol, 133(2), 461–467. https://doi.org/10.1016/j.jaci.2013.08.016